Yusaku Mori

3.0k total citations · 1 hit paper
81 papers, 2.3k citations indexed

About

Yusaku Mori is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Yusaku Mori has authored 81 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Yusaku Mori's work include Pancreatic function and diabetes (20 papers), Diabetes Treatment and Management (19 papers) and Metabolism, Diabetes, and Cancer (11 papers). Yusaku Mori is often cited by papers focused on Pancreatic function and diabetes (20 papers), Diabetes Treatment and Management (19 papers) and Metabolism, Diabetes, and Cancer (11 papers). Yusaku Mori collaborates with scholars based in Japan, Canada and United States. Yusaku Mori's co-authors include Tsutomu Hirano, Y Yazaki, Takashi Kadowaki, Takuya Fujiwara, Y. Akanuma, Kazuhiko Umesono, Hiroyoshi Horikoshi, K Iwamoto, Kohjiro Ueki and Akira Okuno and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yusaku Mori

80 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

1998 875 citations Akira Okuno, Hiroyuki Tamemoto et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Yusaku Mori

Since Specialization

Citations

This map shows the geographic impact of Yusaku Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusaku Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusaku Mori more than expected).

Fields of papers citing papers by Yusaku Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusaku Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusaku Mori. The network helps show where Yusaku Mori may publish in the future.

Co-authorship network of co-authors of Yusaku Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Yusaku Mori. A scholar is included among the top collaborators of Yusaku Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusaku Mori. Yusaku Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Oxidative Stress on Sperm Quality in Oligozoospermia and Normozoospermia Males Without Obvious Causes of Infertility 2024 ·Journal of Clinical Medicine ·(unknown), Yusaku Mori, (unknown), (unknown), Makoto Ohara, Sho‐ichi Yamagishi, Akihiko Sekizawa	3
2	DNA Aptamer Raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing Receptors for Advanced Glycation End Product-Induced Oxidative Stress and Inflammation in the Testes of Diabetic Mice 2024 ·International Journal of Molecular Sciences ·Yusaku Mori, Michishige Terasaki, (unknown), (unknown), (unknown), (unknown), (unknown), Makoto Ohara, Yuichiro Higashimoto, Takanori Matsui, Sho‐ichi Yamagishi	6
3	SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis 2023 ·International Journal of Molecular Sciences ·Michishige Terasaki, Keita Shibata, Yusaku Mori, Tomomi Saito, Takanori Matsui, Makoto Ohara, Tomoyasu Fukui, Keiji Hasumi, Yuichiro Higashimoto, Koji Nobe, Sho‐ichi Yamagishi	8
4	Subcutaneous Infusion of DNA-Aptamer Raised against Advanced Glycation End Products Prevents Loss of Skeletal Muscle Mass and Strength in Accelerated-Aging Mice 2023 ·Biomedicines ·Yusaku Mori, Makoto Ohara, Michishige Terasaki, (unknown), (unknown), Tomomi Saito, (unknown), (unknown), Yuichiro Higashimoto, Takanori Matsui, Tomoyasu Fukui, Sho‐ichi Yamagishi	5
5	Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes 2023 ·Journal of Diabetes Investigation ·(unknown), Tomoyasu Fukui, Yusaku Mori, Munenori Hiromura, Michishige Terasaki, Makoto Ohara, (unknown), (unknown), Yoshihisa Ito, Tetsuro Kobayashi, Sho‐ichi Yamagishi	4
6	Nicotinamide Mononucleotide Prevents Free Fatty Acid-Induced Reduction in Glucose Tolerance by Decreasing Insulin Clearance 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), Sandra Pereira, Yusaku Mori, (unknown), Hilda E. Ghadieh, (unknown), (unknown), Simona S. Ghanem, Suman Asalla, Harrison T. Muturi, (unknown), Jamie W. Joseph, Sonia M. Najjar, Adria Giacca	6
7	Glucose-dependent insulinotropic polypeptide inhibits cardiac hypertrophy and fibrosis in diabetic mice via suppression of TGF-β2 2021 ·Diabetes and Vascular Disease Research ·Munenori Hiromura, Yusaku Mori, Michishige Terasaki, Hideki Kushima, (unknown), (unknown), (unknown), Makoto Ohara, Tomoyasu Fukui, Takanori Matsui, Sho‐ichi Yamagishi	9
8	Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes 2021 ·Diabetes Therapy ·(unknown), Makoto Ohara, (unknown), (unknown), (unknown), (unknown), (unknown), Nobuko Sato, Hideki Kushima, (unknown), (unknown), Munenori Hiromura, Michishige Terasaki, Yusaku Mori, Tomoyasu Fukui, Takanori Matsui, Tsutomu Hirano, Sho‐ichi Yamagishi	4
9	Anti-inflammatory and atheroprotective properties of glucagon 2020 ·Diabetes and Vascular Disease Research ·(unknown), Hideki Kushima, Yusaku Mori, Tomomi Saito, Munenori Hiromura, Michishige Terasaki, (unknown), Makoto Ohara, Tomoyasu Fukui, Takanori Matsui, Tsutomu Hirano, Sho‐ichi Yamagishi	6
10	Pancreatic fat accumulation evaluated by multidetector computed tomography in patients with type 2 diabetes 2020 ·Journal of Diabetes Investigation ·(unknown), Tomoyasu Fukui, (unknown), Munenori Hiromura, Michishige Terasaki, Yusaku Mori, Toshiyuki Hayashi, Takeshi Yamamoto, Makoto Ohara, Satoshi Goto, (unknown), Tsutomu Hirano, Sho‐ichi Yamagishi	7
11	AGE-RAGE Axis Stimulates Oxidized LDL Uptake into Macrophages through Cyclin-Dependent Kinase 5-CD36 Pathway via Oxidative Stress Generation 2020 ·International Journal of Molecular Sciences ·(unknown), Michishige Terasaki, (unknown), Takanori Matsui, Yusaku Mori, (unknown), (unknown), Hideki Kushima, Munenori Hiromura, Makoto Ohara, Tomoyasu Fukui, Sho‐ichi Yamagishi	14
12	A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression 2020 ·International Journal of Molecular Sciences ·Michishige Terasaki, (unknown), Yusaku Mori, Tomomi Saito, Takanori Matsui, Munenori Hiromura, Hideki Kushima, (unknown), Makoto Ohara, Tomoyasu Fukui, Tsutomu Hirano, Sho‐ichi Yamagishi	25
13	Circulating anti‐glutamic acid decarboxylase‐65 antibody titers are positively associated with the capacity of insulin secretion in acute‐onset type 1 diabetes with short duration in a Japanese population 2019 ·Journal of Diabetes Investigation ·(unknown), Tomoyasu Fukui, Yusaku Mori, Toshiyuki Hayashi, Takeshi Yamamoto, Makoto Ohara, (unknown), (unknown), Tetsuro Kobayashi, Tsutomu Hirano	6
14	Association of glucose and blood pressure variability on oxidative stress in patients with type 2 diabetes mellitus and hypertension: a cross-sectional study 2019 ·Diabetology & Metabolic Syndrome ·Makoto Ohara, (unknown), (unknown), (unknown), (unknown), Munenori Hiromura, Takeshi Yamamoto, Yusaku Mori, Toshiyuki Hayashi, Tomoyasu Fukui, Tsutomu Hirano	19
15	Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes 2019 ·Diabetes Research and Clinical Practice ·Makoto Ohara, Munenori Hiromura, (unknown), (unknown), (unknown), Satoshi Goto, Nobuko Sato, Hideki Kushima, Michishige Terasaki, Takeshi Yamamoto, Yusaku Mori, Toshiyuki Hayashi, Tomoyasu Fukui, (unknown), Tsutomu Hirano	9
16	Increased blood pressure in nesfatin/nuclebindin-2-transgenic mice 2017 ·Hypertension Research ·Yusaku Mori, Hiroyuki Shimizu, Hideki Kushima, Munenori Hiromura, Michishige Terasaki, Michitaka Tanaka, Aya Osaki, Tsutomu Hirano	12
17	Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models 2016 ·Circulation Journal ·Munenori Hiromura, Yusaku Mori, (unknown), Michishige Terasaki, (unknown), Takaharu Negoro, (unknown), (unknown), (unknown), Rena Watanabe, Kengo Sato, Hideki Kushima, Masako Tomoyasu, Yasuko Nakano, Yuichiro Yamada, Takuya Watanabe, Tsutomu Hirano	38
18	Effects of PKF275-055, a dipeptidyl peptidase–4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E–null mice 2012 ·Metabolism ·Michishige Terasaki, Masaharu Nagashima, Takuya Watanabe, Kyoko Nohtomi, Yusaku Mori, Ayako Miyazaki, Tsutomu Hirano	56
19	Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease 2007 ·Atherosclerosis ·Toshiyuki Hayashi, Tsutomu Hirano, Takayasu Taira, (unknown), Yusaku Mori, Shinji Koba, Mitsuru Adachi	43
20	Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. breakdown → 1998 ·Journal of Clinical Investigation ·Akira Okuno, Hiroyuki Tamemoto, (unknown), Kohjiro Ueki, Yusaku Mori, K Iwamoto, Kazuhiko Umesono, Y. Akanuma, Takuya Fujiwara, Hiroyoshi Horikoshi, Y Yazaki, Takashi Kadowaki	875

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact